C. Wiel

KRAS Mutations Impact Clinical Outcome in Metastatic Non-Small Cell Lung Cancer

L. Akyürek, J. Nyman, V. Sayin, 2022, Cancers.

Assessing the prognostic value of KRAS mutation combined with tumor size in stage I-II non-small cell lung cancer: a retrospective analysis

V. Sayin, Sama I. Sayin, Henrik Fagman, 2024, Frontiers in Oncology.

KRAS mutations in combination with primary tumor size are not associated with a worse prognosis in early Non-Small Cell Lung Cancer

V. Sayin, H. Fagman, C. Wiel, 2023, medRxiv.